Segawa H, Tsukayama D T, Kyle R F, Becker D A, Gustilo R B
Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA.
J Bone Joint Surg Am. 1999 Oct;81(10):1434-45. doi: 10.2106/00004623-199910000-00008.
The clinical presentation of an infection at the site of a total knee arthroplasty can be used as a guide to treatment, including the decision as to whether the prosthesis should be retained or removed. We reviewed the results of treatment of infection after total knee arthroplasty to evaluate the effectiveness of four treatment protocols based on the clinical setting of the infection.
We retrospectively evaluated the results of treatment of eighty-one infections in seventy-six consecutive patients who either had an infection after a total knee arthroplasty or had multiple positive intraoperative cultures of specimens of periprosthetic tissue obtained during a revision total knee arthroplasty performed because of presumed aseptic loosening. The patients were managed according to one of four protocols. Five infections in five patients who had positive intraoperative cultures were treated with antibiotic therapy alone. Twenty-three early postoperative infections in twenty-one patients were treated with débridement, antibiotic therapy, and retention of the prosthesis. Twenty-nine late chronic infections in twenty-eight patients were treated with a delayed-exchange arthroplasty after a course of antibiotics. Seven acute hematogenous infections in six patients were treated with débridement, antibiotic therapy, and retention of the prosthesis. Seventeen infections in seventeen patients were not treated according to one of the four protocols. Sixteen late chronic infections were treated either with an arthrodesis (five infections) or with débridement, antibiotic therapy, and retention of the prosthesis (eleven infections). One acute hematogenous infection was treated with resection arthroplasty because of life-threatening sepsis.
The mean duration of follow-up was 4.0 years (range, 0.3 to 14.0 years). Eleven patients who had an arthrodesis, a resection arthroplasty, or an above-the-knee amputation after less than two years of follow-up were included in the study as individuals who had a failure of treatment. In the group of patients who were managed according to protocol, the initial course of treatment was successful for all five infections that were diagnosed on the basis of positive intraoperative cultures, five of the ten deep early infections, all thirteen superficial early infections, twenty-four of the twenty-nine late chronic infections, and five of the seven acute hematogenous infections. Only one of eleven prostheses in patients who had a late chronic infection that was not treated according to protocol was successfully retained after débridement.
Our treatment protocols, which were based on the clinical setting of the infection, were successful for most patients. A major factor associated with treatment failure was a compromised immune status. Bone loss and necrosis of the soft tissues around the joint also complicated the treatment of these infections.
全膝关节置换术部位感染的临床表现可作为治疗的指导,包括决定是否保留或移除假体。我们回顾了全膝关节置换术后感染的治疗结果,以评估基于感染临床情况的四种治疗方案的有效性。
我们回顾性评估了76例连续患者中81例感染的治疗结果,这些患者要么在全膝关节置换术后发生感染,要么在因假定无菌性松动而进行的翻修全膝关节置换术中,假体周围组织标本的术中培养多次呈阳性。患者根据四种方案之一进行治疗。5例术中培养阳性患者的5例感染仅接受抗生素治疗。21例患者中的23例早期术后感染采用清创、抗生素治疗并保留假体。28例患者中的29例晚期慢性感染在接受一个疗程的抗生素治疗后采用二期翻修置换术。6例患者中的7例急性血源性感染采用清创、抗生素治疗并保留假体。17例患者中的17例感染未按照四种方案之一进行治疗。16例晚期慢性感染采用关节融合术(5例感染)或清创、抗生素治疗并保留假体(11例感染)进行治疗。1例急性血源性感染因危及生命的脓毒症而采用关节切除成形术治疗。
平均随访时间为4.0年(范围为0.3至14.0年)。11例在随访不到两年后接受关节融合术、关节切除成形术或膝上截肢的患者被纳入研究,作为治疗失败的个体。在按照方案治疗的患者组中,对于所有5例基于术中培养阳性诊断的感染、10例深部早期感染中的5例、所有13例浅表早期感染、29例晚期慢性感染中的24例以及7例急性血源性感染中的5例,初始治疗疗程均成功。在未按照方案治疗的晚期慢性感染患者中,11个假体中只有1个在清创后成功保留。
我们基于感染临床情况的治疗方案对大多数患者是成功的。与治疗失败相关的一个主要因素是免疫状态受损。关节周围的骨质丢失和软组织坏死也使这些感染的治疗复杂化。